Occupe actuellement des postes chez Regulus Therapeutics Inc, Biogen Inc and Exelixis Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Regulus Therapeutics Inc | 11 juin 2013 - |
Independent Chairman of the Board | Biogen Inc | 1 juin 2014 - |
Independent Chairman of the Board, Co-Founder | Exelixis Inc | 1 janvier 1998 - |
Independent Director | Biogen Inc | 1 juillet 2008 - 1 juin 2014 |
Independent Director | Regulus Therapeutics Inc | 2 janvier 2009 - 11 juin 2013 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2022-02-24 | 2022-02-22 |
Exelixis Inc
(EXEL)
|
V Vente |
84 515
-6.5%
19,561 653 113 USD |
84 515 -6.5% | 19,56 | 1 653 113 USD | |
2021-05-13 | 2021-05-11 |
Exelixis Inc
(EXEL)
|
V Vente |
5 473
-0.4%
25,01136 880 USD |
5 473 -0.4% | 25,01 | 136 880 USD | |
2021-05-13 | 2021-05-11 |
Exelixis Inc
(EXEL)
|
V Vente |
5 075
-0.4%
25,00126 875 USD |
5 075 -0.4% | 25,00 | 126 875 USD | |
2021-05-13 | 2021-05-11 |
Exelixis Inc
(EXEL)
|
V Vente |
10 222
-0.8%
24,95255 039 USD |
10 222 -0.8% | 24,95 | 255 039 USD | |
2020-05-08 | 2020-05-08 |
Exelixis Inc
(EXEL)
|
V Vente |
45 000
-4.1%
25,841 162 800 USD |
45 000 -4.1% | 25,84 | 1 162 800 USD | |
2019-05-08 | 2019-05-07 |
Regulus Therapeutics Inc
(RGLS)
|
A Achat |
370 370
+45.2%
1,08400 000 USD |
370 370 +45.2% | 1,08 | 400 000 USD | |
2019-02-22 | 2019-02-21 |
Exelixis Inc
(EXEL)
|
V Vente |
26 250
-2.5%
21,25557 813 USD |
26 250 -2.5% | 21,25 | 557 813 USD | |
2019-01-02 | 2018-12-28 |
Regulus Therapeutics Inc
(RGLS)
|
A Achat |
50 000
+6.4%
1,0954 570 USD |
50 000 +6.4% | 1,09 | 54 570 USD | |
2018-12-28 | 2018-12-26 |
Regulus Therapeutics Inc
(RGLS)
|
A Achat |
90 000
+13.5%
0,9585 878 USD |
90 000 +13.5% | 0,95 | 85 878 USD | |
2017-07-25 | 2017-07-25 |
Regulus Therapeutics Inc
(RGLS)
|
A Achat |
1 000 000
+129.8%
0,91910 000 USD |
1 000 000 +129.8% | 0,91 | 910 000 USD | |
2017-03-23 | 2017-03-21 |
Regulus Therapeutics Inc
(RGLS)
|
A Achat |
200 000
+99.7%
1,20239 800 USD |
200 000 +99.7% | 1,20 | 239 800 USD |